This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Avelos Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Samuele Maramai: Innovator in Pharmaceutical Compounds
Introduction
Samuele Maramai is a notable inventor based in Buonconvento, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific medical conditions.
Latest Patents
Maramai holds a patent for the "Preparation of substituted 1,2-diaminoheterocyclic compound derivatives and their use as pharmaceutical agents." This invention focuses on compounds that act as microtubule associated serine/threonine-like kinase (MASTL) inhibitors. These compounds are particularly relevant in the treatment of diseases mediated by MASTL, including cancer and other related medical conditions.
Career Highlights
Samuele Maramai is associated with Avelos Therapeutics Inc., where he continues to advance his research and development efforts. His work is pivotal in creating innovative solutions for complex health issues.
Collaborations
Maramai collaborates with esteemed colleagues such as Ki Seon Baek and Ja Heouk Khoo, contributing to a dynamic research environment that fosters innovation.
Conclusion
Samuele Maramai's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His work on MASTL inhibitors represents a significant advancement in the treatment of critical diseases.